Be the first to get REACT news and announcements and learn about funding opportunities. Join our email list.
REACT recently awarded funding to five Pilot Studies projects, bringing its total number of awardees to 19 in the past 4 years. Such funding helps catalyze success for these researchers and their teams by providing consultation, seed funds, key expertise, and resources as they conduct innovative pilot projects, early-stage proof-of-concept studies, and futility studies needed to shape more definitive clinical trials.
This July, celebrate the 29th anniversary of the Americans with Disabilities Act (ADA) and learn about advances in the field!
Throughout July, the National Center for Medical Rehabilitation Research will celebrate the 29thanniversary of the Americans with Disabilities Act (ADA) by sharing posts about rehabilitation research achievements of its grantees.
NIH community is seeking input on the progress so far in achieving the priorities in the NIH Research Plan on Rehabilitation
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Center for Medical Rehabilitation Research is inviting comments and suggestions to guide the revision of the Research Plan on Rehabilitation on behalf of the Trans NIH Medical Rehabilitation Coordinating Committee.
NINDS Division of Translational Research has added an additional due date in FY19 for #NIH #HEAL Translational Devices to Treat Pain RFA's.
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has launched a collaborative process to revise and update its strategic plan. The purpose of this Request for Information (RFI) is to solicit feedback on the scientific themes, goals, and opportunities under consideration for the new NICHD strategic plan. Input is requested by February 15, 2019.
NIH Implementation of the Final Rule on the Federal Policy for the Protection of Human Subjects (Common Rule)
The Department of Health and Human Services has updated the Common Rule for Protection of Human Subjects. This will impact specific policies and programs in NIH and implementation as of January 21, 2019, including review of the grant application by the IRB, posting of consent document, and categories of exempt research.
“Design for Rehabilitation – Take the Challenge” – Consortium of Multiple Sclerosis Centers (CMSC) • Feb. 15 – April 15, 2019
This competition is a new event for the Consortium of Multiple Sclerosis Centers (CMSC) 2019 meeting in Seattle, Washington. Partner with your local engineering school and assemble a team to design and fabricate an assistive device specifically for one of your patients or for any other person who would benefit from it.
Email a short letter-of-intent to enter preferably by February 15, 2019 but no later than April 15, 2019.
Dr. Amy Amara, a physician-scientist in the Department of Neurology at UAB and a collaborator in REACT as well as a REACT Pilot Studies award recipient discusses research tools to measure sleep outcomes among patients with Parkinson's disease.
Just Published! Medical Rehabilitation: Guidelines to Advance the Field with High-Impact Clinical Trials
The purpose of this Special Communication is to summarize guidelines and recommendations stemming from an expert panel convened by the National Institutes of Health, National Center for Medical Rehabilitation Research (NCMRR) for a workshop entitled, The Future of Medical Rehabilitation Clinical Trials, held September 2016 at the NCMRR offices in Bethesda, Maryland.
SPARC Partnership Opportunity: Custom Arrangements for Device-Based Clinical Studies with Flexible Data and Intellectual Property Rights
The purpose of this Partnership Opportunity (PO) is to create customized partnerships between NIH and successful applicants to maximize the scientific impact of human device studies through the collection of research data beyond those addressing clinical health end-points.
The Department of Defense Peer Reviewed Orthopaedic Research Program and the Orthotics and Prosthetics Outcomes Research Program, managed by the office of Congressionally Directed Medical Research Programs has just released its fiscal year 2018 funding opportunities.
REACT recently awarded funding to four Pilot Studies projects, bring its total number awardees to 13 in the past 3 years. Such funding helps catalyze success for these researchers and their teams by providing consultation, seed funds, key expertise and resources as they conduct innovative pilot projects, early-stage proof-of-concept studies, and futility studies needed to shape more definitive clinical trials.
Robert Motl, PhD, was recently awarded an National Multiple Sclerosis Society grant to address the growing number of older adults with MS and the normal age-related declines in physical and psychological functioning that are seemingly compounded by the disease and its progression.
NIH has expanded the Inclusion of Children as Participants in Clinical Research Policy to include individuals of all ages.
NICHD funding opportunity: R03 in Archiving and Documenting Child Health and Human Development Data Sets
The purpose of this Notice is to announce an expansion in the scientific topics of interest for applications submitted to the NICHD in response to PAR-16-149 "Archiving and Documenting Child Health and Human Development Data Sets (R03)”.
REACT investigators part of research team awarded $5.7 Million for study on exercise delivery in people with MS
Researchers studying methods of exercise delivery and the effects on people living with multiple sclerosis have been awarded $5.7 million in funding by the Patient-Centered Outcomes Research Institute (PCORI).
Parker Hannifin Corp announces it has received expanded FDA clearance for its Indego exoskeleton, for people with spinal cord injury (SCI) levels T3 and below in home and community settings.
NIH has announced 13 two-year awards to develop 3-D tissue chip research platforms that model disease and test drug efficacy prior to clinical trials. The awards represent the first phase of a 5-year initiative to help scientists better understand disease mechanisms and predict more accurately how patients will respond to specific drugs.
REACT Pilot Awardee receives American Association of Cardiovascular and Pulmonary Rehabilitation Dr. Linda K. Hall Innovation Award
Surya Bhatt, MD, a 2016 REACT Pilot awardee, has received the 2017 American Association of Cardiovascular and Pulmonary Rehabilitation Dr. Linda K. Hall Innovation Award.
Two of the 11 UAB School of Medicine 2017 Dean’s Excellence Awards were given to REACT investigators. The awards are an honor recognizing exceptional contributions made by School of Medicine faculty in service, teaching, research, diversity enhancement and mentorship.
$5.8 Million to study home-based exercise in MS awarded to team including REACT Mobile Tech Lab Director Motl
REACT Mobile Technology Laboratory Director Robert Motl, PhD, is part of a UAB/Lakeshore Foundation team awarded $5.8 million over 4 years by the PCORI Board of Governors to study whether people with multiple sclerosis get as much benefit from an exercise-based telerehabilitation program compared to therapy is provided in a clinic.
Two new technologies that assist in rehabilitation from disabilities, injuries or stroke now have Class II medical device clearance from the Food and Drug Administration.
New discovery in spinal cord injuries shows oxygen can improve blood flow and restore motor function
A new discovery at the University of Alberta will fundamentally alter how we view spinal cord function and rehabilitation after spinal cord injuries (SCI).
Kenneth G. Saag, M.D., Jane Knight Lowe Professor of Medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham, has been elected president of the Board of Trustees of the National Osteoporosis Foundation.
Following an intensive period of research and product development, the Alliance for Innovative Medical Technology — AIMTech— has quickly developed its first product. ResistX will be unveiled at the American College of Sports Medicine Annual Meeting in Boston.